Cardinal Health, Inc. (NYSE:CAH) Stock Position Decreased by Xponance Inc.

Xponance Inc. cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 64,450 shares of the company’s stock after selling 18,008 shares during the quarter. Xponance Inc.’s holdings in Cardinal Health were worth $7,623,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Rothschild Investment LLC boosted its stake in shares of Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock worth $101,000 after acquiring an additional 79 shares in the last quarter. Private Trust Co. NA boosted its position in shares of Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after buying an additional 92 shares during the period. Checchi Capital Advisers LLC boosted its position in shares of Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after buying an additional 93 shares during the period. MWA Asset Management boosted its position in shares of Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock worth $393,000 after buying an additional 95 shares during the period. Finally, Transcend Capital Advisors LLC boosted its position in shares of Cardinal Health by 3.6% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock worth $323,000 after buying an additional 96 shares during the period. 87.17% of the stock is owned by institutional investors.

Cardinal Health Price Performance

NYSE CAH opened at $132.09 on Thursday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The stock’s 50-day moving average is $126.94 and its two-hundred day moving average is $119.78. The firm has a market cap of $31.91 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.53%. Cardinal Health’s payout ratio is presently 37.69%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several recent analyst reports. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. Mizuho initiated coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 target price for the company. Morgan Stanley raised their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research report on Friday, January 31st. Wells Fargo & Company increased their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Finally, JPMorgan Chase & Co. increased their price objective on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.